• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人期开始输血治疗的中间型地中海贫血患者的纵向随访:一项队列研究。

Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.

机构信息

Unità Operativa Semplice Dipartimentale Malattie Rare del Globulo Rosso, Azienda Ospedaliera di Rilievo Nazionale 'A. Cardarelli', Napoli, Italy.

Magnetic Resonance Imaging Unit, Fondazione G. Monasterio CNR-Regione Toscana, Pisa, Italy.

出版信息

Br J Haematol. 2020 Oct;191(1):107-114. doi: 10.1111/bjh.16753. Epub 2020 May 19.

DOI:10.1111/bjh.16753
PMID:32427352
Abstract

We longitudinally evaluated the effects of regular blood transfusions (BTs), in the real-life context of the Myocardial Iron Overload in Thalassaemia network, in patients with thalassaemia intermedia (TI). We considered 88 patients with TI (52 females) who started regular BTs after the age of 18 years. Magnetic resonance imaging was used to quantify iron overload and biventricular function. For 56·8% of the patients there were more than two indications for the transition to regular BTs, with anaemia present in 94·0% of the cases. A significant decrease in nucleated red blood cells, platelets, lactate dehydrogenase, bilirubin, and uric acid levels was detected 6 months after starting regular BTs. After the transition to the regular BT regimen there was a significant increase only in the frequency of hypothyroidism and osteopenia, and a significant decrease in liver iron and cardiac index. The percentage of chelated patients increased significantly after starting regular BTs. The decision to regularly transfuse patients with TI may represent a way to prevent or slow down the natural progression of the disease, despite the more complex initial management.

摘要

我们在铁过载地中海贫血网络的实际环境中对中间型地中海贫血(TI)患者进行了定期输血(BTs)的效果进行了纵向评估。我们考虑了 88 名 TI 患者(52 名女性),他们在 18 岁后开始定期接受 BTs。磁共振成像用于定量铁过载和双心室功能。对于 56.8%的患者,有两个以上的指征需要过渡到定期 BTs,其中 94.0%的病例存在贫血。在开始定期 BTs 后 6 个月,发现有核红细胞、血小板、乳酸脱氢酶、胆红素和尿酸水平显著下降。在过渡到定期 BT 方案后,仅甲状腺功能减退症和骨质疏松症的频率显著增加,而肝铁和心脏指数显著下降。开始定期 BTs 后,螯合治疗的患者比例显著增加。定期为 TI 患者输血的决定可能代表了一种预防或减缓疾病自然进展的方法,尽管初始管理更加复杂。

相似文献

1
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.成人期开始输血治疗的中间型地中海贫血患者的纵向随访:一项队列研究。
Br J Haematol. 2020 Oct;191(1):107-114. doi: 10.1111/bjh.16753. Epub 2020 May 19.
2
Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.重型地中海贫血中的轻度亚临床甲状腺功能减退:患病率、多门控放射性核素检查、临床及实验室长期随访研究
Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:174-80.
3
The impact of genotype on endocrine complications in thalassaemia major.基因型对重型地中海贫血内分泌并发症的影响。
Eur J Haematol. 2006 Aug;77(2):150-6. doi: 10.1111/j.1600-0609.2006.00681.x. Epub 2006 Jun 23.
4
Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.磁共振成像在评估β地中海贫血和镰状细胞病患者铁过载中的应用
Br J Haematol. 2004 Sep;126(5):736-42. doi: 10.1111/j.1365-2141.2004.05104.x.
5
Endocrine complications in patients with Thalassaemia Major.重型地中海贫血患者的内分泌并发症
Pediatr Endocrinol Rev. 2007 Dec;5(2):642-8.
6
Iron status and oxidative stress in beta-thalassemia patients in Jakarta.雅加达β地中海贫血患者的铁状态与氧化应激
Biofactors. 2003;19(1-2):53-62. doi: 10.1002/biof.5520190107.
7
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.通过非常强烈的联合螯合作用使全身铁负荷正常化,可逆转重型地中海贫血的心脏和内分泌并发症。
Br J Haematol. 2010 Feb;148(3):466-75. doi: 10.1111/j.1365-2141.2009.07970.x. Epub 2009 Nov 12.
8
Clinics in diagnostic imaging (29). Thalassaemia major with iron overload.诊断影像学临床(29)。重型地中海贫血伴铁过载。
Singapore Med J. 1997 Sep;38(9):402-4.
9
T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores.中间型地中海贫血定期输血患儿的T2*磁共振成像:血清铁蛋白不能反映肝脏铁储备。
Pediatr Hematol Oncol. 2012 Sep;29(6):579-84. doi: 10.3109/08880018.2012.708891. Epub 2012 Jul 27.
10
Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.镰状细胞贫血和重型地中海贫血慢性输血及螯合治疗患儿铁过载的纵向MRI和铁蛋白监测
J Pediatr Hematol Oncol. 2016 Oct;38(7):497-502. doi: 10.1097/MPH.0000000000000595.

引用本文的文献

1
Prospective Assessment of Cardiac Iron Deposition, Morphology, and Function by Magnetic Resonance Imaging in Non-Transfusion-Dependent and Neo-Transfusion-Dependent Thalassemia.通过磁共振成像对非输血依赖型和新输血依赖型地中海贫血患者心脏铁沉积、形态及功能的前瞻性评估
J Clin Med. 2025 Jun 6;14(12):4020. doi: 10.3390/jcm14124020.
2
Pancreatic Volume in Thalassemia: Determinants and Association with Alterations of Glucose Metabolism.地中海贫血患者的胰腺体积:决定因素及其与糖代谢改变的关联
Diagnostics (Basel). 2025 Feb 26;15(5):568. doi: 10.3390/diagnostics15050568.
3
Renal Findings in Patients with Thalassemia at Abdominal Ultrasound: Should We Still Talk about "Incidentalomas"? Results of a Long-Term Follow-Up.
地中海贫血患者腹部超声检查中的肾脏表现:我们是否仍应提及“偶发瘤”?一项长期随访结果
Diagnostics (Basel). 2024 Sep 15;14(18):2047. doi: 10.3390/diagnostics14182047.
4
Magnetic Resonance Evaluation of Tissue Iron Deposition and Cardiac Function in Adult Regularly Transfused Thalassemia Intermedia Compared with Thalassemia Major Patients.与重型地中海贫血患者相比,成人中间型地中海贫血定期输血患者组织铁沉积和心脏功能的磁共振评估
J Clin Med. 2024 Aug 14;13(16):4791. doi: 10.3390/jcm13164791.
5
Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.中间型地中海贫血患者的心脏磁共振多参数成像:E-MIOT 网络的新见解。
Radiol Med. 2024 Jun;129(6):879-889. doi: 10.1007/s11547-024-01821-y. Epub 2024 Apr 29.
6
Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Neo Transfusion-Dependent Thalassemia.多参数心脏磁共振成像在新输血依赖型地中海贫血中的预后作用
J Clin Med. 2024 Feb 23;13(5):1281. doi: 10.3390/jcm13051281.
7
Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia.基因型对非输血依赖型β-中间型地中海贫血患者多器官铁沉积及并发症的影响。
Ann Hematol. 2024 Jun;103(6):1887-1896. doi: 10.1007/s00277-024-05741-9. Epub 2024 Apr 6.
8
A retrospective study of glucose homeostasis, insulin secretion, sensitivity/resistance in non- transfusion-dependent β-thalassemia patients (NTD- β Thal): reduced β-cell secretion rather than insulin resistance seems to be the dominant defect for glucose dysregulation (GD).一项关于非输血依赖型β地中海贫血患者(NTD-βThal)葡萄糖稳态、胰岛素分泌、敏感性/抵抗性的回顾性研究:对于葡萄糖调节异常(GD),似乎β细胞分泌减少而不是胰岛素抵抗是占主导地位的缺陷。
Acta Biomed. 2023 Dec 5;94(6):e2023262. doi: 10.23750/abm.v94i6.15001.
9
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia.卢司帕安治疗β地中海贫血患者的长期安全性和红系反应
Ther Adv Hematol. 2022 Dec 5;13:20406207221134404. doi: 10.1177/20406207221134404. eCollection 2022.
10
Thalassemia Intermedia: Chelator or Not?中间型地中海贫血:螯合剂治疗,还是不治疗?
Int J Mol Sci. 2022 Sep 5;23(17):10189. doi: 10.3390/ijms231710189.